NWQ Investment Management Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$72.6M Sell
1,203,521
-49,174
-4% -$2.96M 3.28% 2
2020
Q2
$73.7K Sell
1,252,695
-29,986
-2% -$1.79M 2.46% 4
2020
Q1
$71.5M Buy
1,282,681
+17,847
+1% +$1.09M 2.87% 4
2019
Q4
$81.2M Buy
1,264,834
+57,070
+5% +$3.27M 2.02% 6
2019
Q3
$61.2M Buy
1,207,764
+198,451
+20% +$9.33M 1.48% 10
2019
Q2
$45.8M Buy
+1,009,313
New +$47M 1.03% 27

Other funds holding BMY

NWQ Investment Management Company's BMY Position: Q3 2020 in Review

NWQ Investment Management Company reduced its Bristol-Myers Squibb (BMY) stake by 3.9% in Q3 2020, selling an estimated $2.96M and leaving 1,203,521 shares worth $72.6M. The position accounts for 3.28% of the portfolio, ranked #2.

NWQ Investment Management Company first reported a position in BMY in Q2 2019 and has held it in 6 quarters since. The position peaked at $81.2M in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • NWQ Investment Management Company held 1,203,521 shares of Bristol-Myers Squibb worth $72.6M as of Q3 2020.
  • NWQ Investment Management Company sold 49,174 Bristol-Myers Squibb shares in Q3 2020, an estimated $2.96M.
  • Bristol-Myers Squibb made up 3.28% of NWQ Investment Management Company's portfolio in Q3 2020, its #2 holding.
  • NWQ Investment Management Company first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 6 quarters since.
  • NWQ Investment Management Company's Bristol-Myers Squibb position peaked at $81.2M in Q4 2019.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.